Carmell Therapeutics Corporation

Carmell Therapeutics Corporation - PE Ratioverified

CTCX

Price:

$0.1973

Market Cap:

$243.03K

Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the comp...[Read more]

Industry

Biotechnology

IPO Date

2021-09-23

Stock Exchange

NASDAQ

Ticker

CTCX

The PE Ratio as of September 2026 (TTM) for Carmell Therapeutics Corporation (CTCX) is 0.41

According to Carmell Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 0.41. This represents a change of -458.07% compared to the average of -0.11 of the last 4 quarters.

Carmell Therapeutics Corporation (CTCX) Historical PE Ratio (quarterly & annually)

How has CTCX PE Ratio performed in the past?

The mean historical PE Ratio of Carmell Therapeutics Corporation over the last ten years is -5448.71. The current 0.41 PE Ratio has changed -100.75% with respect to the historical average. Over the past ten years (40 quarters), CTCX's PE Ratio was at its highest in in the June 2023 quarter at 4.80K. The PE Ratio was at its lowest in in the June 2021 quarter at -243750.00.

Quarterly (TTM)
Annual

Average

-5448.71

Median

-154.46

Minimum

-26477.06

Maximum

-0.08

Carmell Therapeutics Corporation (CTCX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Carmell Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -0.08

Minimum Annual Increase = -99.55%

Minimum Annual PE Ratio = -26477.06

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.08-99.55%
2024-16.74-89.16%
2023-154.46-74.05%
2022-595.20-97.75%

Carmell Therapeutics Corporation (CTCX) Average PE Ratio

How has CTCX PE Ratio performed in the past?

The current PE Ratio of Carmell Therapeutics Corporation (CTCX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-57.09

5-year avg

-5448.71

10-year avg

-5448.71

Carmell Therapeutics Corporation (CTCX) PE Ratio vs. Peers

How is CTCX’s PE Ratio compared to its peers?

Carmell Therapeutics Corporation’s PE Ratio is greater than Tricida, Inc. (-0.03), greater than Entero Therapeutics, Inc. (-0.69), greater than Tectonic Therapeutic, Inc. (-6.50), greater than Fresh Tracks Therapeutics, Inc. (-0.97), greater than Xenetic Biosciences, Inc. (-3.64), greater than Neuphoria Therapeutics Inc. (-0.35), greater than BiondVax Pharmaceuticals Ltd. (-20.73), greater than Kineta, Inc. (-0.40), greater than Nabriva Therapeutics plc (-0.00), greater than ModivCare Inc. (-0.00),

Build a custom stock screener for Carmell Therapeutics Corporation (CTCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carmell Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carmell Therapeutics Corporation (CTCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carmell Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Carmell Therapeutics Corporation's PE Ratio?

How is the PE Ratio calculated for Carmell Therapeutics Corporation (CTCX)?

What is the highest PE Ratio for Carmell Therapeutics Corporation (CTCX)?

What is the 3-year average PE Ratio for Carmell Therapeutics Corporation (CTCX)?

What is the 5-year average PE Ratio for Carmell Therapeutics Corporation (CTCX)?

How does the current PE Ratio for Carmell Therapeutics Corporation (CTCX) compare to its historical average?